Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by HippygirL74on Mar 28, 2008 12:11am
444 Views
Post# 14915259

RE: Wait a minute.

RE: Wait a minute.This play is not over.  In fact, we are far from over.  Galer was hired to help get Pennsaid passed the FDA.  That is his primary role at this time..  He is DR. Galer and is a pain expert and more scientific than business.

What does the company need a marketing and sales team for?  The plan is to get the product to market and let a distributor with established sales and marketing teams do their part to sell the product.  So of course, all the sales and marketing people have been laid off.  Going it alone in the States would be business suicide.

i am 100% positive that as we approach the FDA resubmission, this stock will rally.   Even a novice can see this.  It happens all the time with all companies waiting for FDA approval.  People get excited.  People get greedy.  Like i said, a rally is coming. 

Pennsaid does sell.  Once again, look at the good sales in Greece.  10% market share there.  Just let the quarters speak for themselves.  If we keep on reading that Greek sales are growing, in a place with only 10 MM people, you can project without too much imagination what American sales might be.  Not a blockbuster, but good enough in its niche. Pennsaid is not first to market, so learn from the mistakes of the first to market and let them open the doors to this delivery method. 

So Pepsi is first to market... thank goodness, Coke never gave up.  Ford was first to market...thank goodness, GM didn't just give up.  And how about Japanese cars... they will never sell much in America.  Yeah right!

imo, it's the FDA's extra request that lead to this shareprice, not management.  Unlike some here, i am indifferent towards  management and the FDA.  i am in this trying to anticipate shareprice movements.  And imo, there will be a big rally in a few more quarters.   But this is a risky stock.   Looks like all or none to me.  The returns are proportional to the risk so place your bets.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse